Iann Rance

Title: Iann Rance: Innovator in Interleukin-7 Polypeptides

Introduction

Iann Rance is a notable inventor based in Sevres, France. He has made significant contributions to the field of biotechnology, particularly in the development of interleukin-7 polypeptides. With a total of 3 patents to his name, Rance is recognized for his innovative approaches to therapeutic applications.

Latest Patents

Rance's latest patents focus on hyperglycosylated mammalian IL-7 IgG conjugate compositions. These inventions relate to new and improved interleukin-7 polypeptides, as well as their preparation and uses. The patents detail hyperglycosylated IL-7 polypeptides that exhibit enhanced properties, along with their manufacturing processes and therapeutic applications. Additionally, the inventions disclose novel IL-7 polypeptides with modified amino acid sequences that contain artificially created glycosylation sites. These advancements also encompass corresponding nucleic acid molecules, vectors, and recombinant host cells, aimed at curative or preventive treatments for mammalian subjects, including humans.

Career Highlights

Iann Rance is currently associated with Cytheris, a company that focuses on innovative biopharmaceutical solutions. His work has contributed to the advancement of therapeutic options in immunology and related fields.

Collaborations

Rance has collaborated with notable colleagues, including Michel Christian Morre and Brigitte Assouline. These partnerships have fostered a collaborative environment that enhances research and development efforts in their respective fields.

Conclusion

Iann Rance stands out as an influential inventor in the realm of interleukin-7 polypeptides, with a focus on improving therapeutic applications. His contributions continue to shape advancements in biotechnology and medicine.